Heart failure (HF) is the single largest cause for increased hospitalization after fine particulate matter (PM2.5) exposure. Patients with left HF often progress to right ventricular (RV) failure even with optimal medical care. An increase of PM2.5 of 10 μg per cubic meter was associated with a 76% increase in the risk of death from cardiovascular disease in 4 years' period. However, the role and mechanism of PM2.5 in HF progression are not known. Here we investigated the role of PM2.5 exposure in mice with existing HF mice produced by transverse aortic constriction (TAC). TAC-induced HF caused lung inflammation, vascular remodeling and RV hypertrophy. We found increased PM2.5 profoundly exacerbated lung oxidative stress in mice with existing left HF. To our surprise, PM2.5 exposure had no effect on LV hypertrophy and function, but profoundly exacerbated lung inflammation, vascular remodeling, and RV hypertrophy in mice with existing left HF. These striking findings demonstrate that PM2.5 and/or air pollution is a critical factor for overall HF progression by regulating lung oxidative stress, inflammation and remodeling as well as RV hypertrophy. Improving air quality may save HF patients from a dismal fate.
The inflammatory response after myocardial infarction (MI) is a precisely regulated process that greatly affects subsequent wound healing and remodeling. However, understanding about the process is still limited. Macrophages are critically involved in inflammation resolution after MI. Krüppel-like factor 9 ( Klf9 ) is a C2H2 zinc finger–containing transcription factor that has been implicated in glucocorticoid regulation of macrophages. However, the contribution of Klf9 to macrophage phenotype and function in the context of MI remains unclear. Our study revealed that KLF9 deficiency resulted in higher mortality and cardiac rupture rate, as well as a considerable exacerbation in cardiac function. Single-cell RNA sequencing and flow cytometry analyses revealed that, compared with WT mice,
Klf9
–/– mice displayed excessive neutrophil infiltration, insufficient macrophage infiltration, and a reduced proportion of monocyte-derived CD206 + macrophages after MI. Moreover, the expression of IFN-γ/STAT1 pathway genes in
Klf9
–/– cardiac macrophages was dysregulated, characterized by insufficient expression at 1 day post-MI and excessive expression at day 3 post-MI. Mechanistically, Klf9 directly binds to the promoters of Stat1 gene, regulating its transcription. Overall, these findings indicate that Klf9 beneficially influences wound healing after MI by modulating macrophage recruitment and differentiation by regulating the IFN-γ/STAT1 signaling pathway.
Pulmonary thrombosis is a fatal complication observed in patients following severe trauma or pulmonary infections. Patients with existing heart failure (HF) are more susceptible to infection-induced lung thrombosis; however, the underlying mechanisms remain poorly understood. This study introduces a severe mouse pulmonary thrombosis model utilizing CD40 knockout (KO) mice following transverse aortic constriction (TAC)-induced HF. While CD40 KO was found to have no detectable effect on left ventricular (LV) structure or function in mice either after TAC or under control conditions, the CD40 KO mice developed profound pulmonary micro-thrombosis after TAC. CD40 deficiency also significantly exacerbated TAC-induced pulmonary leukocyte infiltration (such as total CD45+ cells, Mac2+ cells and CD3+ cells), ∼1.7-fold more pulmonary fibrosis, and pulmonary vessel remodeling, as well as the consequent right ventricular hypertrophy. Mechanistically, our findings indicate that CD40 KO significantly enhanced TAC-induced pulmonary oxidative stress and pulmonary vascular endothelial cell activation, as indicated by upregulated vascular cell adhesion molecule-1 (VCAM-1) and intercellular cell adhesion molecule-1 expression (ICAM-1). Moreover, CD40 KO and TAC synergistically augmented thrombin (49.1 ± 3.0 in CD40 KO TAC group vs 27.2 ± 4.8 in WT TAC group), collagen (51.4 ± 2.5 in CD40 KO TAC group vs 37.8 ± 2.4 in WT TAC group), and ADP-induced platelet aggregation (40.1 ± 2.1 in CD40 KO TAC group vs 31.0 ± 1.8 in WT TAC group) and blood clot contraction(0.92 ± 0.01 in CD40 KO TAC group vs 0.72 ± 0.03 in WT TAC group) in mice. Furthermore, mild but significant pulmonary micro-thrombosis and increased blood clot retraction (0.80 ± 0.02 in CD40 KO sham group vs 0.66 ± 0.02 in WT sham group) were also observed in CD40 KO mice under baseline (control) conditions. Collectively, these results demonstrate that the profound pulmonary micro-thrombosis observed in CD40 KO mice is the outcome of a synergistic effect involving an inherent platelet defect in CD40 KO mice, combined with HF-induced pulmonary endothelial oxidative stress, endothelial activation, and systemic platelet activation. This unique lung micro-thrombosis model may serve as a useful tool for investigating the mechanisms and therapeutic strategies for pulmonary micro-thrombosis, particularly under conditions of existing HF.
6 January 2026 in Journal of the American Heart Association
Background: The subendocardial viability ratio (SEVR) reflects myocardial perfusion relative to workload. This study explored the association of SEVR with mortality and subclinical target organ damage in an older adult population. Methods: We analyzed the data from the Northern Shanghai Study, a community‐based cohort of older adults aged over 65 years. SEVR was measured with arterial tonometry. Cross‐sectional associations were assessed between SEVR levels and target organ damage (including arterial stiffness, peripheral artery disease, carotid plaque, left ventricular hypertrophy, left ventricular diastolic dysfunction, chronic kidney dysfunction, and microalbuminuria). Longitudinal associations between SEVR and mortality were evaluated using Cox and Fine‐Gray models. Results: Among 3237 participants (mean age 71±6 years, 57% female), 233 deaths occurred over a median follow‐up of 5.7 years, including 94 cardiovascular deaths. Participants were divided into 2 groups by the median value of SEVR (129%). The group with a lower SEVR (≤129%) was associated with higher risk of cardiovascular death (adjusted Cox Hazard Ratio [HR]=1.70 [1.05–2.75]; P =0.03), but not with all‐cause death (adjusted Cox HR=1.30 [0.98–1.73]; P =0.07). As for target organ damage, participants with more damaged organs had lower SEVR values ( P for trend <0.001). Specifically, the occurrence of arterial stiffness and left ventricular diastolic dysfunction increased the potential of worse SEVR, with odds ratio 1.46 (1.17–1.83); P <0.001, and 1.90 (1.35–2.67); P <0.001, respectively. Conclusions: Lower SEVR is independently associated with both increased cardiovascular mortality and organ damage, including arterial stiffness and left ventricular diastolic dysfunction in older adult populations. SEVR may be a convenient marker for early cardiovascular risk stratification in aging populations. Registration: URL: https://ClinicalTrial.gov ; Unique Identifier: NCT02368938.